1996
DOI: 10.1046/j.1432-0436.1996.6050309.x
|View full text |Cite
|
Sign up to set email alerts
|

Human insulin gene expression in transgenic mice: mutational analysis of the regulatory region

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
5
0

Year Published

1999
1999
2021
2021

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 36 publications
(90 reference statements)
1
5
0
Order By: Relevance
“…It contains important regulatory motifs (Fig. 1a) previously used to make reporters for identifying INS + cells [6], [12]. We first confirmed the utility of this region to report insulin production by transfecting a phINS-EGFP construct (Fig.…”
Section: Resultssupporting
confidence: 55%
“…It contains important regulatory motifs (Fig. 1a) previously used to make reporters for identifying INS + cells [6], [12]. We first confirmed the utility of this region to report insulin production by transfecting a phINS-EGFP construct (Fig.…”
Section: Resultssupporting
confidence: 55%
“…Interestingly, systematic in vitro binding studies and episomal reporter assays have disclosed >16 binding activities and functional elements in the human insulin promoter, yet did not highlight the critical role of the CC sequence prior to the human genetic findings 4,[22][23][24][25][26] . A mutation of a 34 bp region that contains the CC element in randomly integrated human INS promoter transgenics did not significantly alter promoter activity 54 . This indicates that the essential function of the CC element to create active chromatin can only become fully apparent in a natural chromatinized environment, such as that of human patients or mutant HIP mice.…”
Section: Discussionmentioning
confidence: 88%
“…pCAGRm was constructed by replacing a DNA fragment encoding the EYFP protein of pCAGYm with a Bam HI– Not I fragment encoding the DsRed1 protein of pDsRed1‐N1. pInsG was constructed by inserting a insulin enhancer/promoter (−363 to +15) [28], which was obtained by polymerase chain reaction from a healthy human volunteer using the forward primer: 5′‐GACAGCAGCGCAAAGAGCCCCGCCCTGC‐3′ and the reverse primer: 5′‐CTGTCCTGGAGGGCTGAGGGCTGCTGGG‐3′, into the Ase I and Sac II sites of pEGFP‐N1 (Clontech, USA). pCAGRm‐InsG and pCAGRm‐InsG(R) were constructed by inserting a 1.3 kb Spe I– Afl II fragment of pInsG into the Hin dIII site of pCAGRm.…”
Section: Methodsmentioning
confidence: 99%